TP53 and ovarian cancer: The results showed that although TP53-related radiomics features varied to some extent among the three tumor types, as shown in panels m–p of Figure 5, when cervical cancer, ovarian cancer, and endometrial cancer data were integrated for unified analysis, significant differences in tumor structural features (CT radiomics features) and metabolic features (PET radiomics features) were still observed between the TP53-negative and TP53-positive groups.